101 related articles for article (PubMed ID: 9396638)
1. The evolution of antithrombotic therapy in coronary stenting.
Schatz RA
Am Heart J; 1997 Nov; 134(5 Pt 2):S78-80. PubMed ID: 9396638
[TBL] [Abstract][Full Text] [Related]
2. Rationale for low-molecular weight heparin in coronary stenting.
Zidar JP
Am Heart J; 1997 Nov; 134(5 Pt 2):S81-7. PubMed ID: 9396639
[TBL] [Abstract][Full Text] [Related]
3. Contemporary antithrombotic strategies in patients undergoing coronary stent implantation.
Bartorelli AL; Trabattoni D
Minerva Cardioangiol; 2002 Oct; 50(5):517-30. PubMed ID: 12384634
[TBL] [Abstract][Full Text] [Related]
4. [Post-implant antithrombotic treatment after intracoronary stents. Thrombotic occlusion].
Alonso Martín JJ; Durán Hernández JM; Gimeno de Carlos F; de la Fuente Galán L; Muñoz San José JC; Fernández-Avilés F
Rev Esp Cardiol; 1997; 50 Suppl 2():31-43. PubMed ID: 9221455
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic therapy after intracoronary stenting.
Spinler S; Cheng J
Pharmacotherapy; 1997; 17(1):74-90. PubMed ID: 9017767
[TBL] [Abstract][Full Text] [Related]
6. Periprocedural and medium-term antithrombotic strategies in patients with an indication for long-term anticoagulation undergoing coronary angiography and intervention.
Rubboli A; Colletta M; Herzfeld J; Sangiorgio P; Di Pasquale G
Coron Artery Dis; 2007 May; 18(3):193-9. PubMed ID: 17429293
[TBL] [Abstract][Full Text] [Related]
7. Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation.
Helft G; Gilard M; Le Feuvre C; Zaman AG
Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):673-80. PubMed ID: 17122800
[TBL] [Abstract][Full Text] [Related]
8. Safety of an aspirin-alone regimen after intracoronary stenting with a heparin-coated stent: final results of the HOPE (HEPACOAT and an Antithrombotic Regimen of Aspirin Alone) study.
Mehran R; Aymong ED; Ashby DT; Fischell T; Whitworth H; Siegel R; Thomas W; Wong SC; Narasimaiah R; Lansky AJ; Leon MB
Circulation; 2003 Sep; 108(9):1078-83. PubMed ID: 12925457
[TBL] [Abstract][Full Text] [Related]
9. [Influence of various antithrombotic therapy methods on the incidence of subacute coronary stent occlusions, hemorrhagic complications and length of hospitalization].
Facchini M; Muntwyler J; Schuiki E; Rickli H; Kiowski W; Amann FW
Schweiz Med Wochenschr; 1998 Jan; 128(3):72-9. PubMed ID: 9498258
[TBL] [Abstract][Full Text] [Related]
10. Individualized antithrombotic therapy in high risk patients after coronary stenting. A double-edged sword between thrombosis and bleeding.
May AE; Geisler T; Gawaz M
Thromb Haemost; 2008 Mar; 99(3):487-93. PubMed ID: 18327396
[TBL] [Abstract][Full Text] [Related]
11. [Antithrombotic treatment after coronary stenting in patients with an indication to oral anticoagulation: what are the possible strategies?].
Rubboli A; Di Pasquale G
G Ital Cardiol (Rome); 2006 Jan; 7(1):68-73. PubMed ID: 16528965
[No Abstract] [Full Text] [Related]
12. Low molecular weight heparin in coronary stenting.
Zidar JP
Can J Cardiol; 1998 Aug; 14 Suppl E():35E-39E. PubMed ID: 9779032
[TBL] [Abstract][Full Text] [Related]
13. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
Wolak A; Amit G; Cafri C; Gilutz H; Ilia R; Zahger D
Int J Cardiol; 2005 Sep; 103(3):293-7. PubMed ID: 16098392
[TBL] [Abstract][Full Text] [Related]
14. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
[TBL] [Abstract][Full Text] [Related]
15. What is the role for improved long-term antiplatelet therapy after percutaneous coronary intervention?
Steinhubl S; Berger P
Am Heart J; 2003 Jun; 145(6):971-8. PubMed ID: 12796751
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.
Orford JL; Fasseas P; Melby S; Burger K; Steinhubl SR; Holmes DR; Berger PB
Am Heart J; 2004 Mar; 147(3):463-7. PubMed ID: 14999195
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
Spinler SA
Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
[TBL] [Abstract][Full Text] [Related]
18. Timing of thrombotic events in patients receiving 2 weeks of clopidogrel therapy post bare metal coronary artery stenting: a New Zealand retrospective study.
Tie S; Wong CK; Yap J; Wilkins G; Williams M; Kay P
N Z Med J; 2007 Jun; 120(1255):U2553. PubMed ID: 17546101
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry.
Machecourt J; Danchin N; Lablanche JM; Fauvel JM; Bonnet JL; Marliere S; Foote A; Quesada JL; Eltchaninoff H; Vanzetto G;
J Am Coll Cardiol; 2007 Aug; 50(6):501-8. PubMed ID: 17678732
[TBL] [Abstract][Full Text] [Related]
20. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
Roldán V; Marín F
Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
[No Abstract] [Full Text] [Related]
[Next] [New Search]
